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Tubular action of diuretics: Distal effects on electrolyte transport and
acidification. We used clearance and free-flow micropuncture tech-
niques to evaluate the influence of several diuretic agents, given both
individually and in various combinations, on transport of sodium,
potassium, and fluid, and on acidification and ammonium transport,
within the distal tubule of the rat kidney. The loop diuretics, furosemide
and piretanide, sharply increased fractional delivery of fluid, sodium,
and potassium into the distal tubule, and, as a result, sodium reabsorp-
tion and potassium secretion were enhanced in this nephron segment.
These two drugs also stimulated urinary acidification and increased
urinary phosphate, titratable acid, and ammonium excretion. These
effects took place both within the loop of Henle and along the distal
tubule. Amiloride and triamterene alone inhibited distal tubular sodium
reabsorption and potassium secretion, and, when given with one of the
loop diuretics, suppressed both the kaliuresis and the increased acid
and ammonium excretion induced by the latter agents.
Hydrochlorothiazide and tizolemide inhibited sodium reabsorption
within the distal tubule, and were associated with a stimulation of
potassium secretion within this segment. Addition of one of these two
latter distally acting agents to either of the loop diuretics led to a further
augmentation of sodium excretion, but to a reduction of potassium
excretion, compared to the responses seen after the loop diuretics
alone.
Action tubulaire des diuretiques: Effets distaux sur le transport des
electrolytes et sur l'acidification. Nous avons utilisC des techniques de
clearance et de microponction en flux libre pour évaluer l'influence de
diffCrents agents diurétiques, donnés soit seuls, soit en diverses asso-
ciations, sur le transport de sodium, de potassium et de liquides et sur
l'acidification et Ic transport d'ammonium, dans le tubule distal de rein
de rat. Les diurCtiques de l'anse, Ic furosémide et Ic pirCtanide, ont
augmenté de facon aigue la fraction délivrCe deliquides, de sodium, et
de potassium au tubule distal, et, par consequent, Ia reabsorption de
sodium et La secretion de potassium ont etC stimulCes dans cc segment
néphronique. Ces deux mCdicaments ont Cgalement stimulé l'acidifica-
lion urinaire et augmente les phosphates urinaires, l'aciditC titrable et
l'excrCtion d'ammonium. Ces effets ont eu lieu a Ia fois dans l'anse de
Henlé et le long du tubule distal. L'amiloride et le triamtèrCne seuls ont
inhibé Ia reabsorption tubulaire distale de sodium et Ia secretion de
potassium, et, lorsqu'ils étaient administrés avec l'un des diuretiques de
l'anse, us ont suppnmC Ia kaliurèse et l'augmentation d'exci-Ction
d'acide et d'ammonium induites par ces derniers mCdicaments.
L'hydrochlorothiazide et Ic tizolémide ont inhibé Ia reabsorption de
sodium dans Ic tubule distal et étaient associds a une stimulation de la
secretion de potassium dans cc segment. L'addition de ces agents a
action distale a l'un des diurétiques de l'anse a abouti a une plus grande
augmentation de l'excrCtion de sodium, mais a une reduction de
l'excrCtion de potassium par rapport aux reponses observCes apres les
diuretiques de l'anse seuls.
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Micropuncture studies in rodents and dogs and experiments
on isolated segments of rabbit tubules have outlined the main
tubular sites of action of diuretic agents. In general, diuretics
act at well-defined nephron sites by inhibiting salt and water
reabsorption. As a result of their primary tubular actions,
frequently they effect delivery of a larger fluid load to more
distally located nephron sites. Thus, even when these sites are
not directly affected by the diuretic, the final action of a given
agent will be modified significantly by secondary effects on the
transport function of more distal segments. For instance, ad-
ministration of a diuretic with a primary site of action on the
thick ascending limb of Henle's loop leads to the delivery of a
dramatically increased fraction of the filtrate into the distal
tubule, and to powerful stimulation of sodium reabsorption and
of potassium secretion, along this tubular segment [1, 2].
In this work, we have extended previous studies on the distal
tubular effects of several diuretics, and, in addition, have
investigated whether the secondary effects of loop diuretics
upon distal tubular transport functions can be modified by
diuretic agents known to have a more distal site of action. We
chose two powerful diuretics, furosemide and piretanide,
known to act predominantly upon the thick ascending limb of
Henle's loop [3—5], and studied the interactions of these agents
with diuretics having a more distal tubular site of action. Among
these, amiloride and triamterene have been shown to act on the
late distal tubule and the cortical collecting tubule [1, 71,
whereas hydrochlorothiazide and a new agent, tizolemide, have
their main effect on the early distal tubule [6, 8]. We observed
striking modifications of the secondary distal effects of furose-
mide and piretanide by these diuretics.
Two groups of experiments were carried out. In one group,
the effects of various diuretics upon distal tubular fluid, sodium,
and potassium transport were studied. In a second group, the
effects of the same diuretics and their combinations upon distal
tubular acidification and ammonium transport were evaluated.
Methods
Clearance and free-flow distal tubular micropuncture studies
were performed in two groups of male Sprague-Dawley rats
(mean body wt: 258 13.4 g), anesthetized by the
intraperitoneal injection of mactin (100 mg/kg body wt). The
animals were fasted for 16 hr before the beginning of the study,
but had free access to water. The methods used for micropunc-
ture and localization of the tubular collection site have been
described previously [1].
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Table I.
Experimental condition
Number of
animals used
Amount of drug given
mg- kg' hr' i.v.
Furosemide 10 5.0
Piretanide 11 5.0
Hydrochlorothiazide 10 30.0
Tizolemide 10 30.0
Triamterene 9 5.0
Amiloridea 10 2.4
Furosemide + amiloride 6 5.0 + 5.0
Furosemide + triamterene 6 5.0 + 5.0
Piretanide + amiloride 6 5.0 + 5.0
Piretanide + triamterene 6 5.0 + 5.0
Furosemide +
hydrochlorothiazide 10 5.0 + 30.0
Furosemide + tizolemide 6 5.0 + 30.0
a Amiloride data were taken from Duarte, Chomety, and Giebisch [1].
After preparation of the kidneys, a bolus injection of 75 Ci
inulin-3H in 0.7 ml Ringers' solution was given, followed by
infusion of a bicarbonate (25 mEq/liter)-Ringer's solution at a
rate of 2.5 mi/hr/bOg body wt. The sustaining infusion deliv-
ered 75 pCi inulin-3H per hr. During a control period, com-
mencing 45 mm after beginning the intravenous infusion, fluid
samples were obtained from 3 to 4 distal tubular sites. Diuretic
infusion was initiated then, and after a 30-mm equilibration
period, several more distal tubules were punctured during the
diuretic state. Distal tubules were identified by one or two
intravenous injections of lissamine green. In general, the tu-
bules were repunctured, but samples collected from early and
late distal tubules were not obtained uniformly from the same
nephron. The collection rate was calculated by measuring the
volume of a timed collection in a constant bore glass capillary
tube that had been calibrated with a solution containing tritiated
inulin. The rate of intravenous fluid infusion was adjusted and
increased appropriately to replace urinary losses during the
periods following the administration of the various diuretics.
The experimental conditions and number of animals used are
summarized in Table 1.
The mono-sodium-salt of the diuretics furosemide and
piretanide were dissolved in Ringer's solution and infused
intravenously at 5.0 mg/kg per hr. Amiloride was dissolved in
Ringer's solution with an appropriate amount of 0.2 M NaOH
added to adjust the pH to 11.5. Hydrochlorothiazide was
dissolved similarly, but in 0.1% NaCI solution. Triamterene was
dissolved according to Wiebelhaus et al [91 and infused sepa-
rately through a second jugular catheter. Tizolamide, a diuretic
belonging to a new class of thiazolidin-sulfonamide derivatives
[8], was dissolved also in 0.9% saline.
At the end of the experiment the punctured tubules were
filled with Microfil (Canton Bio-Medical Products, Boulder,
Colorado, USA). The kidneys were digested then in 25%
NaOH, after which the tubules were microdissected for local-
ization of the tubular collection site. For calculation of mean
early and late distal values, samples were pooled from 20 to
60% and from 61 to 100% of distal tubular length, respectively.
Inuiin-3H activity was measured in urine and plasma samples
by liquid scintillation spectrometry. Isotopic counting was done
by a Searle Analytical 92 spectrophotometer in a 77% solution
of Aquasol (New England Nuclear, Boston, Massachusetts,
USA) in water for 100,000 total counts and a correction applied
for the quenching effect of lissamine green. Sodium and potas-
sium concentrations were measured in samples of proximal and
distal fluid with a Helium-Glow Spectrophotometer (Aminco,
Silver Spring, Maryland, USA), and in urine and plasma by
standard flame photometry. Titratable acid (TA), defined as the
acid equivalent, at pCO2 = 0, between the sample pH and blood
pH (taken to be 7.4), was measured both in final urine and in
distal tubular samples. The methods for measuring TA and
ammonium in urine and in 2.5 nl tubular fluid samples by
coulometry have been described fully in previous studies [101.
Distal tublular pH was measured in situ using antimony elec-
trodes that had been calibrated at the temperature of the kidney
in bicarbonate-free phosphate buffers [11]. The total phosphate
concentration was 5 m, a value similar to that observed during
saline diuresis in rat distal tubule [12]. Phosphate in the final
urine was measured by the method of Chen, Torigara and
Warner [13] and by the method of Hurst [14]. In the latter
instance, the samples were diluted with 1% H2S04 and
dialysed, thereafter, ammonium-molybdate and SnCI2-hydrazin-
sulphate were added. The color reaction at room temperature
was measured photometrically at 660 nm (Technicon Instru-
ments Corporation, Tarrytown, New York, USA). Ammonia in
the urine samples was determined enzymatically according to
DaFonseca-Wollheim [15].
All data are expressed as mean values SEM. Statistical
evaluation was performed using Student's t test (paired and
unpaired data) and analysis of variance. Comparison of the
effects of loop diuretics alone with controls was done by
Student's t test for paired data. Comparison of the effects of
combinations of diuretics with loop diuretics alone was per-
formed by one way analysis of variance. Comparison of the
effect of combinations of diuretics with controls (no diuretic)
was done by Student's t test for unpaired data.
Results
Effects of diuretics and their combinations on glomerular
filtration rate, and the excretion rates of sodium and
potassium
As shown in Table 2, compared to control conditions, furo-
semide and piretanide increased urine volume dramatically.
The other diuretics led also to a significant but much smaller
increase in urine flow rates. With respect to the effects of
various combinations of diuretics, we observed no major
change in urine flow rates after such combinations compared to
furosemide and piretanide given alone. Only when piretanide
and triamterene were administered together was there a signif-
icant fall in urine flow, as compared to the effect of the more
potent diuretic given alone. With respect to glomerular filtration
rate (GFR), none of the diuretics given alone led to a major
change. Only the administration of the loop diuretics, furose-
mide and piretanide with hydrochiorothiazide or with
tizolemide, led to a moderate but significant fall in GFR. The
reason for this modest decline of GFR is not known, but was
not related to a fall in mean arterial blood pressure (see Table
3). Conceivably, it could be related to an additive effect of loop
diuretics with distally acting diuretics on intratublar hydrostatic
pressure. The latter would be expected to increase more as fluid
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Table 2. Summary of urine flow rates, urinary concentration ratios, and fractional excretion of sodium and potassium
Vol
,al mm kg'
GFR
ml min' kg-i Inulin U/P Na U/P Na/In U/P K U/P K/In U/P
Controls 20.0 6.0
(16)
9.50 1.50
(16)
658 93.40
(16)
0.35 0.15
(16)
0.001 0.0002
(16)
63.10 17.25
(16)
0.111 0.031
(16)
Furosemide 998 101b
(8)
9.82 0.73
(7)
10.06 1.25"
(8)
0.96 0.03"
(8)
0.082 0.008"
(8)
4.55 0.55"
(8)
0.455 0.045"
(8)
Piretanide 855 137b(II) 11.07 180b(10) 13.23 276b(11) 0.96 0.03"(11) 0.078 0.007"(11) 5.46 1.20"(11) 0.419 0078b(11)
Hydrochloro- 275 35.7" 9.89 0.41 42.02 10.07" 1.68 0.38" 0.043 0.004" 8.49 1.36" 0.192 0019b
thiazide (10) (10) (10) (10) (10) (10) (10)
Tizolemide 303 34.9"
(10)
12.09 2.28"
(10)
45.45 985b
(10)
2.07 0.18"
(10)
0.049 0009b
(10)
8.41 2.51"
(10)
0.187 0028b
(10)
Triamterene 56.6 70b
(9)
9.74 0.73
(9)
130.40 401b
(9)
3.15 0.25"
(9)
0.025 0006b
(9)
4.06 0.90"
(9)
0.031 0.008"
(9)
Amiloridea 320 139b
(32)
8.83 052b
(26)
25.36 380b
(32)
0.75 0.05"
(32)
0.053 0009b
(32)
1.85 040b
(32)
0.084 08b
(32)
Furosemide + 939 27gb 8.44 065b 10.32 193b 1.06 002bc 0.107 0022bc 1.13 031bc 0.110 0.027C
amiloride (6) (6) (6) (6) (6) (6) (6)
Furosemide + 907 230" 10.83 1.42 13.08 454b 1.02± 007bC 0.093 0033b 2.03 041bc 0.152 0.054C
triamterene (6) (6) (6) (6) (6) (6) (6)
Piretanide + 805 210" 11.21 3.14 12.73 2.88" 1.14 0.04C 0.093 0.0l1C 1.04 0.52 0.084 0.045c
amiloride (6) (6) (6) (6) (6) (6) (6)
Piretanide + 636 660c 9.24 0.05C 14.65 1.61" 1.12 0.04C 0.087 0.007" 2.40 035bc 0.167 0.037C
triamterene (6) (6) (6) (6) (6) (6) (6)
Furosemide + 1055 84.1" 7.39 0.42C 745 105bc 0.93 004b 0.120 0.013IC 2.11 0.24" 0.301 0.076C
hydrochloro- (10) (10) (10) (10) (10) (10) (10)
thiazide
Furosemide + 911 125" 7.05 090bc 8.44 241b 0.91 0.03"' 0.107 0.023"' 1.84 0.32"' 0.221 0070bc
tizolemide (6) (6) (6) (6) (6) (6) (6)
Piretanide + 1004 216b 7.16 0.31"' 6.27 026bc 0.96 006b 0.159 0.009"' 2.11 0.44"' 0.340 0050""
tizolemide (6) (6) (6) (6) (6) (6) (6)
a Data from Duarte, Chomety, and Giebisch [1].
b Comparison with control (P < 0.05).
Comparison of the combination with ioop diuretic alone; either furosemide or piretanide (P < 0.05).
Number in parentheses denotes number of animals used.
reabsorption is inhibited at the two tubular sites (loop and distal
tubule).
Fractional excretion rates of sodium were augmented
sharply, to some 8% of the filtered load, after furosemide and
piretanide. As shown in Table 3, this corresponds to an absolute
increase in sodium excretion rates from the control value of
0.63 to 139.6 14.50 and 125.1 27.2 tmo1e/min kg' body
wt after furosemide and piretanide, respectively. The other
diuretics given alone led to smaller but still significant incre-
ments of fractional sodium excretion.
It is apparent from inspection of Table 2 that the simulta-
neous administration of ioop diuretics with drugs such as
amiloride, triamterene, hydrochiorothiazide, and tizolemide, all
of which act further downstream along the nephron, led to a
further increase in fractional sodium excretion. Thus, approxi-
mately 8% of the filtered sodium load was excreted when the
loop diuretics fuorsemide and piretanide are given alone, but
fractional sodium excretion observed during various combina-
tions of diuretics ranged from 8.7 to 15.9% of the filtered sodium
load.
Compared to control conditions, in which 11% of the filtered
potassium load was excreted, both furosemide and piretanide
led to sharp increments in fractional excretion rates, reaching
values of 45.5 and 41.9%, respectively. Table 3 summarizes
representative examples of mean plasma electrolytes and uri-
nary sodium and potassium excretion rates and blood pressure
values in control conditions and after administration of diuretics
and their combination. Mean absolute excretion rate of potas-
sium was increased from a control value of 2.50 0.40
mole/min' kg' body wt to 17.5 1.2 and 18.2 2.85
jmole/min' kg after furosemide and piretanide, respec-
tively. Both hydrochlorothiazide and tizolemide increased uri-
nary fractional potassium excretion significantly, to a value of
about 19%. In sharp contrast, both triamterene and amiloride
reduced fractional potassium excretion to values significantly
below control excretion rates.
The combined administration of loop diuretics with either
amiloride or with triamterene completely or largely suppressed
the kaliuresis observed after administration of either furose-
mide or of piretanide alone. Fractional potassium excretion
after giving furosemide or piretanide together with either
amiloride or triamterene led to the excretion of only some 8 to
16.7% of the filtered potassium, a value in the range of control
excretion rates. It is of interest to note that although
hydrochiorothiazide and tizolemide, given alone, are kaliuretic,
their combined administration with either furosemide or
piretanide led to a moderate but significant reduction of frac-
tional potassium excretion compared to that seen after either
loop agent alone. Also, the simultaneous administration of
piretanide, tizolemide, and triamterene reduced potassium ex-
cretion rate to about half of the excretion rate during piretanide
and tizolemide administration. This shows an inhibitory effect
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Table 3. Summary of plasma sodium and potassium concentration and urinary excretion of sodium and potassium
Piretanide +
Control Furosemide Piretanide amiloride
Plasma Na 145.80 1.75 145.53 2.91 147.07 2.40 147.22 2.91
(mmole/liter) (16) (8) (11) (6)
Plasma K 4.30 0.45 3.96 0.33 4.18 0.31 4.96 0.59
(mmo!e/liter) (16) (8) (11) (6)
Urine Na 44.75 7.98 139.8 3.30a 142.27 5.27a 187.10 49.36
(rnmolelliter) (16) (8) (11) (6)
Na excretion 0.63 0.26 139.6 l4.5a 125.1 27.2a 135.4 35.P
(mole/min kg body WI) (16) (8) (11) (6)
Urine K 222.43 77.14 17.67 1.77a 22.80 5.13 5.20 251ab
(mmole//iter) (16) (8) (11) (6)
K excretion 2.5 0.4 17.5 1.2 18.2 2.8a 4,1 23ab
(pmo!e/min . kg bod,v WI) (16) (8) (11) (6)
Blood pressure 115 7 113 9 111 7 112 8
mmHg (16) (8) (11) (6)
a Comparison with control (P < 0.05).
b Comparison of the combination with loop diuretic alone; either furosemide or piretanide (P < 0.05).
Number in parentheses denotes number of animals used.
Note: Since the results of combinations of furosemide and piretanide with other diuretics were similar, they were excluded.
Table 4. Summary of urinary pH, TA, NH4 and P04
TA NH4 P04
Experimental [TAI [NH4] [P04] r.tmo1e j.mo1e .uno1e
condition pH mmole/liter mmole/lier mmole/liter min' kg-I min' kg1 min' kg—I
Control (N = 6) 6.02 0.28 125.2 17.2 160 13.7 107.5 20.6 1.63 0.43 2.12 0.41 1.41 0.6
Furosemide (N = 6) 5.16 0.40a 4.24 0.85 7.04 l.02a 5.10 0.38a 4.25 0.92a 7.05 l.l3a 5.07 o.35
Piretanide (N = 6) 5.25 0.26 3.68 0.79a 5.29 1.77a 6.09 0.54a 3.27 0.86a 4.83 2.03a 4.93 0.9
Furosemide +
amiloride (N = 6) 6.40 O.lIth 2.99 O.47' 4.16 l.l3 5.62 Q57a 2.57 035ab 345 153ab 483 0.54
Furosemide +
triamterene
(N = 6) 6.59 052ab 2.32 083ab 477 184ab 7.58 131ab 1.90 096b 4.06 l.lla1 4.82 0.07k
Piretanide +
triamterene
(N = 6) 6.79 0,39ab 1.20 039aab 4.28 082aab 6.66 2.27a 0.73 026ab 2.54 039ab 4.41 1.65k
a Comparison with control (P < 0.05).
b Comparison of the combination with loop diuretic alone; either furosemide or piretanide (P < 0.05).
N = number of animals used.
of triamterene on potassium excretion stronger than that of
tizolemide.
We conclude from these urinary excretion data that those
potassium-sparing diuretics that suppress potassium excretion
when given alone, are able to reduce sharply the kaliuresis that
follows administration of loop diuretics (Tables 2 and 3). At the
same time, these diuretics effect further augmentation of the
fractional excretion of sodium. Some diuretics, such as
hydrochiorothiazide and tizolemide, kaliuretic when given
alone, can curtail excretion of potassium when given together
with loop diuretics.
Table 4 summarizes the effects of some of the diuretics upon
urinary pH and the excretion rates of titratable acid (TA),
ammonium, and phosphate. The following are the key observa-
tions. Both furosemide and piretanide decreased urinary pH
and augmented urinary excretion of TA, NH4 and phosphate.
At the low urinary pH of 5.16 and 5.25, observed after furose-
mide and piretanide administration, respectively, urinary bicar-
bonate excretion must have been minimal. Hence, it is safe to
assume that net acid excretion, that is, [TA + NH4 — HC03]
was enhanced following both loop diuretics. A decrease in
urinary pH after furosemide has also been described by Flores,
de Mello Aires, and Malnic [16].
Simultaneous administration of furosemide with either
amiloride or with triamterene, or the addition of triamterene to
piretanide, led to a consistent modification of the urinary
acidification pattern just described. Compared to the effects of
furosemide alone, the combined administration of this diuretic
with either amiloride or with triamterene raised urinary pH
sharply, to values above those observed under control condi-
tions. As expected, this was associated with a significant fall in
TA excretion. It should be noted that neither amiloride nor
triamterene led to a significant modification of the enhanced
urinary phosphate excretion that was uniformly seen after the
administration of the two ioop diuretics.
The effects of triamterene upon urinary pH and excretion
rates of TA, NH4 and phosphate were similar to those noted for
amiloride. Thus, compared to the effects of piretanide given
alone, triamterene not only raised pH but also curtailed the
excretion of TA and of NH4. It did not, however, lower the
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Table 3. Continued
Piretanide +
triamterene
Hydrochioro-
thiazide Tizolemide
Piretanide +
tizolemide
148.07 2.66a 145.45 3.70 147.40 2.43 143.00 212ab
(6) (10) (10) (6)
4.25 0.20 4.17 0.20 4.09 0.19 4.41 0.39
(6) (10) (10) (6)
166.1 817ab 237.37 46.52a 301.63 24.02a 156.50 545kb
(6) (10) (10) (6)
105.5 10.5a 61.7 54 61.2 18.4a 175.2 212ab
(6) (10) (10) (6)
10.47 l.94' 24.03 5.88a 38.60 17.40a 5.51 0.95'
(6) (10) (10) (6)
6.7 17ab 6.8 2.9a 6.5 3.1 59 15ab
(6) (6) (10) (6)
116 11 114 7 113 9 112 9
(6) (10) (10) (6)
increased phosphate excretion rate observed when piretanide
was given alone.
Micropuncture data
Table 5 and Figures 1 and 2 provide information on distal
tubular fluid and electrolyte transport. The following are the
most important changes.
First, delivery of fluid into the distal tubule was elevated only
modestly after administration of some of the diuretics or their
combination. In sharp contrast, the delivery of fluid out of the
distal tubule was increased several fold in all experimental
conditions in which diuretics or their combinations were admin-
istered. Thus, fluid reabsorption along the distal tubule was
reduced almost always.
Second, fractional sodium delivery into the early distal tubule
was elevated significantly compared to controls after all diuret-
ics except in the case of amiloride and triamterene given alone.
This is expected from the established site of action of these
diuretics at more distal tubular sites [1, 71. The administration
of all diuretics also resulted in a significant elevation of the
tubular sodium concentration, as indicated by the consistent
rise in early and late TFIP Na ratios. The fraction of sodium
delivered into the distal tubule was largest after furosemide and
piretanide, and their combination with hydrochlorothiazide and
tizolemide. Confirming previous observations [1, 17, 18], we
noted that the fractional sodium delivery into early distal
tubules was about 20% of the filtered load after loop diuretics,
compared with somewhat more than 9% after hydrochiorothi-
azide or tizolemide. It should be pointed out that combinations
of either furosemide or piretanide with triamterene resulted in
lower fractional sodium deliveries into the early distal tubule as
compared with the sodium delivery rates into the distal tubule
after loop diuretics alone.
Third, inspection of Table 5 and of Figure 1 indicates that the
delivery of larger than normal fractions of sodium into the distal
tubule following loop diuretics results in stimulation of sodium
reabsorption along the distal tubule. Under control conditions,
only some 4% of the filtered sodium is reabsorbed, some 7 to
12.5% of sodium is reabsorbed after administration of furose-
mide or piretanide, respectively. Stimulation of distal tubular
sodium transport after loop diuretics has been observed in
previous studies also [1]. Despite the fact that sodium delivery
was increased also, albeit less, after chlorothiazide and after
tizolemide, sodium reabsorption was not augmented (Table 5).
Inhibition of distal tubular sodium transport after chlorothiazide
and after tizolemide is indicated by the fact that the differences
between early and late distal tubular fractional delivery rates
are not statistically significant. As reported previously [1],
distal sodium transport was inhibited from 4 to 1.5% after
amiloride. We also observed curtailment of sodium transport
after triamterene, since fractional sodium deliveries remained
essentially unchanged along the distal tubule. Lacy, Dobyan,
and Jamison [7] have noted the enhanced delivery of sodium
into the late distal tubule after triamterene also.
As further shown in Table 5 and in Figure 2, hydrochlorthi-
azide, amiloride, triamterene, and tizolemide had a stimulating
effect on distal tubular sodium transport when given simulta-
neously with either furosemide or piretanide. Sodium reabsorp-
tion along the distal tubule was 1.5, 2.0 and 2.0%, respectively,
after amiloride, tizolemide, and hydrochlorothiazide alone, it
was increased significantly to 8.1, 6.0, and 10.0 after combined
administration of fuorsemide with amiloride, tizolemide, and
hydrochiorothiazide. Furthermore, the combined application of
piretanide with either amiloride or tizolemide increased tubular
sodium reabsorption to 7.6 and 10.0%, respectively, as com-
pared to lower rates of sodium reabsorption after amiloride or
tizolemide given alone (Table 5). It is noteworthy that the
augmentation of distal tubular sodium transport under such
conditions is uniformly associated with higher luminal sodium
concentration. This is apparent from inspection of early distal
TFIP Na ratios after hydrochiorothiazide, tizolemide, triamter-
ene, and amiloride alone, compared with these ratios after the
combined administration of these four diuretics with either
furosemide or piretanide.
Table 5 and Figures 1 and 2 illustrate the effects of various
diuretics given alone and of their combinations upon distal
tubular potassium transport. Data from control animals are
given for comparison.
Confirming previous studies on the action of loop diuretics
[1], potassium TFIP ratios were increased significantly at the
early distal tubular level after furosemide and piretanide, com-
pared to control conditions. In addition, a sharp rise was noted
in early distal potassium delivery to approximately 28%, com-
pared to 5.5% in control, non-diuretic conditions. Fractional
potassium delivery out of the distal tubule was enhanced also.
Accordingly, fractions of potassium equivalent to approxi-
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Table S. Summary of distal nicropuncture data
Experimental
condition
Flow, ni/mm In TF/P
—
Na TF/P
Early Late Early Late Early Late
Controls 4.4 0.9
(10)
1.3 0.2
(16)
5.80 1.63
(10)
19.12 3.44
(16)
0.29 0.05
(10)
0.20 0.04
(16)
Furosemide 5.4 1.4
(6)
3.6 l.0
(7)
4.55 o,3Q
(6)
9.61 2.65a
(7)
0.97 0.06
(6)
0.91 0.08
(7)
Piretanide 6.2 l.l
(8)
3.1 1.5
(7)
4.41 0.76a
(7)
9.22 2.19a
(8)
092 0.17
(6)
0.88 0.23a
(7)
Hydrochlorothiazide 7.3 l.4
(6)
4.5 0.8a
(6)
4.52 Q43a
(6)
8.81 0.3l
(6)
0.49 0.09
(7)
0.71 0.17k
(7)
Tizolemide 7.6 0.9a
(6)
4.0 l.1
(6)
4.09 0.54
(6)
8.53 1.40
(6)
0.40 0.06a
(6)
0.65 0.l8a
(7)
Triamterene 5.5 0.9
(8)
2.5 0.4
(7)
6.75 0.35a
(8)
14.21 2.07a
(7)
0.31 0.04
(8)
Q,54a 0.06
(8)
Amiloridec 5.6 0.8
(7)
2.5 Ø5a
(6)
6.37 0.49a
(6)
15.10 1.97
(6)
0.36 0.05
(9)
0.61 0.OSa
(8)
Furosemide + 5.7 1.3 3.5 o.9 5.34 1.05a 8.02 0.66a 0.80 O.13 0.86 0.o2
amiloride (7) (6) (6) (6) (7) (6)
Furosemide + 5.0 0.9 2.7 0.9w' 6.21 0.56' 8.99 2.07a 0.65 0.l2' 0.60 0.05
triamterene (6) (16) (6) (17) (6) (7)
Piretanide + 6.2 1.9 3.8 isa 5.20 052ab 8.30 2.79a 0.87 0.lla 0.91 o.loa
amiloride (7) (9) (7) (6) (7) (10)
Piretanide + 4.2 01b 3.2 0.7 5.34 0.35 7.67 0.72a 0.67 008ab 0.52 005ab
triamterene (6) (6) (6) (6) (6) (6)
Furosemide + 5.4 1.5 4.1 l.0 4.51 0.5W' 8.04 0.88 0.91 0.05a 0.92 0.05a
hydrochlorothiazide (13) (9) (14) (9) (14) (9)
Furosemide + 5.1 1.1 3.9 o9 4.61 0.24a 8.75 0.7P 0.80 Q,07ab 0.90 o.o7
tizolemide (9) (8) (6) (8) (6) (6)
Piretanide + 6.2 1.2 3.8 0.8k 3.95 0.94" 9.10 2.01" 0.92 0.08" 0.94 0.06
tizoleniide (6) (6) (6) (6) (6) (6)
a Comparison with control (P < 0.05).
b Comparison of the combination with loop diuretic alone; either furosemide or piretanide (P < 0.05).
Data from Duarte, Chomety, and Giebisch [1].
Number in parentheses denotes number of animals used.
mately 46 to 49% of the filtered potassium load were present at
the late distal tubule as compared to some 13% under control
conditions. In control animals, an amount equivalent to 7.5% of
the filtered load was secreted along the distal tubule. Following
administration of furosemide or piretanide, an amount equiva-
lent to 21% and 17.6% of the filtered load was secreted (Table
5). Hydrochlorothiazide and tizolemide both raised distal tubu-
lar potassium secretion sharply above control values, as can be
seen by inspection of late distal K/In TF/P ratios in control and
hydrochiorothiazide- or tizolemide-treated rats. After hydro-
chlorothiazide, the amount secreted corresponded to 19.1%,
after tizolemide to 14.2%, compared to a control value of 7.5%
(Table 5). As expected from their late distal and collecting duct
action, neither amiloride nor triamterene raised early distal
tubular potassium delivery. Amiloride blocked potassium se-
cretion, whereas triamterene induced net potassium reabsorp-
tion (Table 5).
The most striking effect of the administration of loop diuretics
with either amiloride or with triamterene was the sharp reduc-
tion of distal tubular potassium secretion. Despite the persis-
tence of a significant natriuretic effect following furosemide and
piretanide administration, distal tubular potassium transport
changed to net reabsorption when amiloride was added to the
loop diuretics, This is evident from inspection of Table 5,
showing that amounts equivalent to 5.0 and 5.4% of filtered
potassium were reabsorbed along the distal tubule after furose-
mide and amiloride, or after piretanide and amiloride. This
effect is much less pronounced after furosemide or piretanide in
combination with triamterene. One striking difference between
the effects of amiloride and of triamterene should be noted.
While the addition of amiloride to furosemide or to piretanide
did not affect fractional potassium delivery into the distal
tubule, triamterene lowered potassium entry into this nephron
segment sharply (Table 5).
Both hydrochiorothiazide and tizolemide increased distal
tubular potassium secretion. Not only were the delivery rates of
potassium into the distal tubule augmented sharply, but secre-
tion was enhanced sharply also. Thus, compared to a mean
control value of 13% at the end of the late distal tubule in
control conditions, hydrochlorothiazide, and tizolemide in-
creased these values to 34 and 29%, respectively. Although the
delivery of potassium into the final urine was less than that into
the late distal tubule of superficial nephrons, either due to
reabsorption of potassium along the collecting duct system or
due to lower potassium delivery by juxtamedullary nephrons,
final potassium excretion after these two diuretic compounds
remained elevated above control values.
It should be noted that both diuretics, although clearly
kaliuretic as just described, failed to enhance distal potassium
secretion when given together with either fuorsemide or
piretanide. Early distal potassium TF/P ratios were comparable
to those after loop diuretics, late distal tubular potassium TF/P
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Table 5. Continued
NaJIn TF/P K TF/P K/In TF/P
Early Late Early Late Early Late
0.050 0.01 0.0097 0.0035 0.35 0.15 2.88 0.46 0.055 0.015 0.128 0.024
(10) (14) (10) (16) (10) (16)
0.185 0.02 0.113 ØØ43 1.45 0.42a 3.73 l.02a 0.281 0.l2 0.491 0.08
(6) (7) (6) (6) (6) (6)
0.218 0.07a 0.093 0.033a 1.42 0.40a 3.58 l.08 0.286 0.09a 0.462 0.07
(6) (6) (6) (6) (6) (6)
0.095 0.023a 0.075 0.023a 0.88 0.39a 2.58 0.67 0.145 0.02P 0.336 0.093
(6) (7) (7) (7) (6) (7)
0.096 0.024a 0.076 0.034a 0.87 0.44a 2.62 0.53 0.150 o.ola 0.292 0.04
(7) (7) (6) (7) (6) (7)
0.045 0.006 0.038 O.OO7 0.54 0.07a 0.72 0.02a 0.08 0.023a 0.051 0.003
(7) (7) (7) (7) (7) (6)
0.056 0.007 0.041 0.008a 0.45 0.05 0.92 0.03a 0.065 0.015 0.061 0.02k
(9) (8) (9) (8) (9) (8)
0.181 0.037a 0,10 O.046a 2.25 0.33 1.54 024ab 0.248 0.061a 0.198 0.052
(7)
0.116 0.046a
(6)
0.071 002ab
(7)
0.55 O.O4'
(6)
0.76 024ab
(6)
0.10 0022ab
(6)
0.081 0032ab
(6) (7) (6) (7) (6) (7)
0.211 0.041 0.135 0.039' 1.21 0.25a 1.52 037ab 0.237 0.049 0.183 0049ab
(9) (10) (7) (9) (9) (7)
0.115 0,Ø3ab 0.081 0.012a 0.52 0.03" 0.76 0.12 0.11 0•041b 0.119 0,053b
(6)
0.245 0028ab
(6)
0.14 0.07
(6)
1.55 0.05'
(6)
2.55 061b
(6)
0.31 0.066k
(6)
0.332 0.07
(8) (9) (6) (9) (7) (9)
0.21 0.06a 0.15 0.06k 1.51 032ab 2.50 0.50" 0.29 ØQ7 0.281 006b
(6) (6) (6) (6) (6) (6)0.24 0.12a 0.14 0.06a 1.25 065ab 2.52 0.75 0.30 0.06a 0.312
(6) (6) (6) (6) (6) (6)
ratios were distinctly lower (2.50 to 2.55) when furosemide or
piretanide were given together with hydrochiorothiazide or
tizolemide as compared to the effects of loop diuretics alone
(3.58 to 3.73). Accordingly, fractional potassium delivery out of
the distal tubules decreased significantly, to about 28 to 33%, as
compared to loop diuretics alone (46 to 49% of filtered potas-
sium). This corresponds to the fact that an amount almost
equivalent to 20% of the filtered potassium load was secreted
along the distal tubule during furosemide or piretanide admin-
istration, but this secretion was effectively suppressed when
combinations of the two diuretics (furosemide +
hydrochlorothiazide, furosemide + tizolemide, piretanide +
tizolamide) were given (Table 5).
Table 6 summarizes several acidification parameters obtained
in distal tubular micropuncture experiments. Since no pH
changes were seen along the distal tubule, the results of pH
measurements were pooled. A significant finding was the reduc-
tion of distal tubular fluid pH following the administration of
either furosemide or piretanide. Triameterene, when given
together with piretanide, completely blocked the acidifying
effect of piretanide. Not shown in this table are the results of a
series of experiments in which the effects of triamterene, given
alone, were studied. Distal tubular control pH was 6.55, but the
value of pH measurements after triamterene was significantly
elevated (P 6.75 0.05, N = 10).
As observed previously in micropuncture studies [11, 19], the
concentration of TA and of NH4 increased along the distal
tubule. This functional pattern was accentuated by either of the
two loop diuretics. Thus, late distal tubular concentrations of
TA were moderately but significantly increased in furosemide-
and piretanide-treated animals. Since we observed in this study
that the rate of fluid delivery is also significantly increased
following both loop diuretics, from 1.3 nI/mm in control animals
to 3.64 nI/mm and to 3/07 nI/mm after furosemide and
piretanide, respectively (Table 5), it is safe to conclude that the
rate of TA delivery out of the distal tubule was enhanced
proportionately. The situation with ammonium is similar. With
the observed increase in distal tubular flow rate, late distal
ammonium concentration essentially remained unchanged, in-
dicating enhanced ammonium flow out of the distal tubule. The
concentration of ammonium at the late distal tubular level was
less after piretanide + triamterene than when piretanide was
given alone, and indicates that triamterene reverses the stimu-
lating efl'ect of the ioop diuretic on distal tubular ammonium
excretion.
Discussion
The experiments of this study confirm the powerful diuretic
actions of furosemide and piretanide in the loop of Henle. In
addition, we have demonstrated a stimulatory effect of loop
diuretics upon distal acidification, titratable acid, and ammo-
nium secretion. Amiloride and triamterene, when given simul-
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Fig. 1. Effect of furosemide and piretanide on
fractional delivery of sodium and potassium
(percentage of filtered load) to early and late distal
puncture sites, and into the final urine. Symbols
are: D, control;, furosemide; iii, piretanide.
Fig. 2. Effect of furosemide alone, and the
combination of furosemide with amiloride, and
piretanide with amiloride on fractional delivery of
sodium and potassium (percentage offiltered load)
to early and late distal puncture sites, and into the
final urine. Symbols are: , furosemide;,
furosemide + amiloride; ui, piretanide +
amiloride.
taneously with loop diuretics, further enhance sodium excretion, but
suppress the increase in distal potassium secretion that occurs when
loop diuretics are administered alone. Similarly, amioride and
triamterene also reverse the changes in acid and ammonium excre-
tion that follow administration of loop diuretics.
To explain our findings on sodium, potassium, and acid
transport within the framework of cellular transport models of
the loop of Henle and the distal tubule that have recently been
developed, Figure 3 schematically summarizes relevant trans-
port operations in a cell of the thick ascending limb. As shown,
the cells lining the thick ascending limb are characterized by a
luminal cotransport mechanism for sodium-chloride-potassium
[20, 46]. Its high sensitivity to loop diuretics such as furosemide
and piretanide is well established [4, 21, 46, 47]. This nephron
segment has a lumen-positive transepithelial potential, a high
luminal potassium conductance and a peritubular ATP-ase
driven sodium-potassium exchange pump that lowers cell so-
dium and thus generates a steep sodium concentration gradient
across the luminal cell membrane. In an electroneutral mode of
operation, both the concentration gradients of sodium and
chloride favor the net reabsorptive movement of sodium and of
chloride and potassium.
Effects on sodium, potassium, and fluid transport
Loop diuretics
The main site of furosemide and piretanide action within the
nephron is the loop of Henle, particularly the thick ascending
limb where these diuretics exert a powerful inhibition of so-
dium, chloride, and potassium reabsorption 13, 23, 241. This is
evident from the observation that the concentrations of these
ions in the early distal tubular fluid are strikingly elevated. The
fractional delivery of these ions into the distal tubule is in-
creased significantly also. The observed increased fluid delivery
into the early distal tubule is likely due, at least in part, to
diminished fluid reabsorption along the descending limb of
Henle's loop. Fluid absorption at this site is driven by the axial
osmolality gradient from cortex to papilla [25], which is reduced
following administration of loop diuretics [26]. Such decreased
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Table 6. Summary of [TA], [NH4] and pH in distal tubules
pH
[TA], mmolelliter [NH4], mmole/liter
early late early late
Control 6.55 0.01
(13)
2.50 0.77
(10)
7.77 0.78
(11)
2.60 0.30
(7)
5.85 0.46
(10)
Furosemide 6.03 0.04a
(9)
3.95 0.25
(12)
9.05 O57
(7)
2.30 0.37
(6)
6.58 o.soa
(8)
Piretanide 6.12 0.05
(8)
3.47 0.26a
(8)
10.0 l.22a
(5)
2,28 0.37
(6)
5.79 0.31
(7)
Piretanide + triamterene 6.52 004ab
(9)
2.33 0.53"
(7)
3.18 026ab
(7)
2.96 0.53"
(7)
4.03 0.28'
(7)
a Comparison with control (P < 0.05).
b Comparison of the combination with loop diuretic alone; either furosemide or piretanide (P < 0.05).
Number in parentheses denotes number of animals used.
fluid reabsorption could also obligate enhanced potassium de-
livery out of the loop of Henle.
Several lines of evidence suggest that at least two factors
contribute to the kaliuresis following administration of loop
diuretics. First, potassium reabsorption is specifically inhibited
by interaction of furosemide and piretanide with the Na-K-
2C1 cotransport system in the luminal cell membrane of the
thick ascending limb [4, 211. In addition, potassium reabsorp-
tion could occur via the paracellular shunt pathway, being
driven by the lumen-positive potential [3]. Since the latter is
abolished or sharply reduced after loop diuretics, such a passive
mechanism of K reabsorption would be attenuated also.
Second, the overall kaliuretic effect is closely related to the
ability of loop diuretics to increase fluid delivery into the late
distal tubule and to stimulate distal potassium secretion as a
consequence of the well-established strong flow sensitivity of
the distal tubular potassium transport system [2, 271. Recent
microperfusion studies have demonstrated directly that furose-
mide also inhibits sodium chloride reabsorption by the distal
tubule [28], and this is thought to be an additional factor
responsible for the significantly enhanced fluid delivery into the
late distal tubule, the main site of potassium secretion. Distal
tubular potassium transport appears not to be affected directly
by these agents. This view is supported by microperfusion
studies of superficial distal tubules in the rat [28]. When flow
rate is kept constant, addition of furosemide to the luminal fluid
does not enhance potassium secretion.
Two mechanisms have been suggested to account for the
flow-dependence of distal tubular potassium secretion. On the
one hand, several studies performed under free-flow conditions
have found that as flow rate increases, potassium secretion is
stimulated while luminal potassium concentration is relatively
unchanged [27]. Since sodium reabsorption also increases un-
der these conditions, it was postulated that stimulation of
peritubular sodium-potassium exchange was responsible for
building up cell potassium concentrations, thus favoring in-
creased secretion into the lumen [27]. A different mechanism of
flow-dependent stimulation of distal tubular potassium secre-
tion has been deduced from distal tubular microperfusion
experiments [29]. It was observed that under controlled condi-
tions of flow rate and sodium concentration, potassium secre-
tion could be stimulated without enhanced tubular sodium
reabsorption. A consistent observation of these experiments
was a flow-dependent fall in luminal potassium concentration as
flow rate along the distal tubule was accelerated. It was
concluded that the increase in the potassium concentration
gradient across the luminal cell membrane was responsible for
the enhancement of potassium secretion [29].
Inspection of relevant potassium concentrations in the pre-
sent experiments (Table 5) shows that the sharp stimulation of
distal tubular potassium secretion, from 7.5% in controls to
21.0% and 17.5%, after furosemide and piretanide occurred
without a fall in luminal potassium concentration. Thus, in the
case of furosemide, end-distal luminal flow rate increased from
a control value of 1.33 nL/min to 3.64 nI/mm, at a time when
corresponding early and late distal TF/P potassium ratios in-
creased from control values of 0.35 and 2.88 to diuretic values
of 1.45 and 3.73, respectively. Taken together with the mini-
mally lowered plasma K after furosemide (Table 3), it is clear
that the concentration profile of potassium along the distal
tubule in furosemide-treated rats was elevated rather than
depressed during the increase in luminal flow rate. We conclude
that under conditions of increased fluid delivery following loop
diuretics, stimulation of potassium secretion is not dependent
on a fall in luminal potassium concentration, but is linked to
enhanced sodium reabsorption.'
Distally acting diuretics and combinations of agents
The effects of amiloride on distal tubular function may be
summarized as an inhibition of tubular sodium reabsorption
together with an inhibition of potassium secretion. By analogy
with its action on several epithelia in vitro [30], it is thought that
amiloride blocks the luminal sodium permeability of those distal
tubule cells that transport sodium and potassium ions. Studies
on single mammalian collecting duct cells are in agreement with
this tubular mode of action of amiloride [31, 32]. Although
direct evidence is not available, it is likely that triamterene acts
in a similar manner.
As shown here, the superimposition of diuretic agents such as
amiloride or triamterene, both acting at the distal tubule, upon
'The situation is different after administration of furosemide with
amiloride, when sodium reabsorption is stimulated yet potassium
reabsorption was observed. In this situation, amiloride inhibits potas-
sium secretion presumably by hyperpolarization of the apical cell
membrane [32]. Hence, the stimulating effect of sodium now is coun-
teracted by the distal inhibitory effect of amiloride on potassium
secretion.
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Fig. 3. Schematic model of a cell from the thick ascending limb of
Henle's loop. The primary active transport mechanism for sodium and
potassium is shown in the basolateral membrane (shaded), while other
co- and counter-transport mechanisms are indicated by open circles in
the appropriate membranes. Movement by passive electrodiffusion is
indicated by broken lines. The lumen has a positive electrical potential
relative to the interstitium.
furosemide and piretanide, has variable and, at best, only small
additional inhibitory effects upon distal sodium transport. It is
likely that this attentuation of the amiloride effect on distal
tubular sodium transport after loop diuretics is related to the
dramatically higher luminal sodium concentrations that are
present in the distal tubule under these conditions (Table 5).
Elevated luminal sodium concentrations could maintain sodium
entry into distal tubule cells despite the amiloride-induced
reduction of luminal sodium permeability. Such a mechanism of
interaction is likely in view of the demonstrated sensitivity of
distal tubular net sodium reabsorption to the stimulating effect
of tubular sodium concentration 1331.
The mechanism of action of amiloride upon distal tubular
potassium transport is related to its effect upon distal tubular
sodium permeability. As a consequence of the reduced luminal
sodium permeability, the apical cell membrane hyperpolarizes
and the lumen-negative potential declines after amiloride [1, 31,
32, 36], Since potassium entry into the distal tubular lumen is
dependent upon a favorable electrochemical driving force, such
luminal hyperpolarization will oppose cellular egress of potas-
sium and reduce net secretion 1341. It is virtually certain that
amiloride acts similarly in the presence of loop diuretics, and
suppresses the sharply augmented potassium secretion second-
ary to its effect on the sodium transport pathway and the
electrical polarization of the apical cell membrane.
The distal cellular mechanism of action of triamterene is less
well defined. Thus, whether a mode of action similar to that of
amiloride accounts also for the tubular action of triamterene
and for the interaction between loop diuretics and this diuretic
is not known. However, we consider it likely in view of the
close similarity of its effects when compared to those of
amiloride. One significant difference between the action of
amiloride and of triamterene was noted, however, and that was
our discovery that administration of the two loop diuretics,
furosemide and piretanide, together with triamterene signifi-
cantly reduced the delivery of sodium into the distal tubule
compared to the two loop diuretics given alone. Such an effect
was not observed with amiloride (Table 5). Furosemide and
piretanide, when given alone, effect the delivery of 18.5 and
21.8% of the filtered sodium into the early distal tubule, but the
combination of these diuretics with triamterene reduced early
distal delivery rates to 11.6 and 11.5%, respectively. It has been
well established by microperfusion studies in vivo and in vitro
that loop diuretics act primarily from the lumen and that
furosemide is secreted into the proximal tubule via the anion-
secretory pathway [37]. The transport of loop diuretics into the
lumen is thus a factor in determining the diuretic response by
affecting the access route of the diuretic to its site of action [38].
It has been shown recently in micropuncture experiments that,
during continuous infusion of furosemide, the administration of
triamterene inhibits the secretion of furosemide into the proxi-
mal tubule [39]. As a consequence, it is possible that the
effective concentration of loop diuretics is reduced at the level
of the thick ascending limb of Henle, resulting in a smaller
inhibition of reabsorptive sodium, chloride, and potassium
transport. As a consequence, the delivery of these ions into the
distal tubule is reduced.
It should be noted further that the weaker inhibition of
sodium chloride transport along Henle's loop by the combined
administration of the loop diuretics with triamterene is associ-
ated with no apparent modification of sodium transport along
the distal tubule and along the collecting duct. Urinary sodium
excretion remains unaltered or even slightly increased after
combination of triamterene with furosemide or piretanide (see
Table 2).
Both hydrochlorothiazide and tizolemide have major diuretic
effects along the distal convoluted tubule. Kunau, Weller, and
Webb [6] and Costanzo and Windhager [40] have observed
inhibition of distal tubular chloride and sodium transport by
thiazides. The effects of tizolemide on urinary sodium and
potassium transport are quite similar to those of hydrochloro-
thiazide (Table 2). It should be noted that in addition to the
effects of these agents on the distal tubule itself, both diuretics
increased fractional fluid and sodium delivery into the distal
tubule. This indicates that, in addition to their distal tubular site
of action, hydrochlorothiazide and tizolemide also inhibit fluid
and salt transport at nephron sites prior to the distal tubule.
Although our data do not allow localization of this inhibitory
action, it is known that thiazides possess appreciable capacity
to inhibit carbonic anhydrase [41], and an effect on proximal
tubular electrolyte and fluid reabsorption, secondary to this
action, has been proposed [42]. The results of this study suggest
that this proximal effect contributes importantly to the overall
diuretic response to these agents.
It is of interest that tubular sodium transport and the diuretic
action of both hydrochlorothiazide and tizolemide were modi-
fied markedly by furosemide and piretanide. Although sodium
transport clearly was inhibited along the distal convoluted
tubule when these two diuretics were given alone, appreciable
sodium reabsorption along this nephron segment was evident
when hydrochiorothiazide or tizolemide were given together
with either of the two loop diuretics (Table 5). Again, it is likely
that this attenuation of the distal inhibitory effect of
hydrochlorothiazide and of tizolemide on sodium transport is
due to the higher sodium concentration along the distal tubule
that results from the inhibition of loop sodium chloride reab-
sorption by furosemide or piretanide. However, fractional
urinary excretion of sodium was still higher during combined
treatment with the two types of diuretics compared to the
Na *
2 Cl
K
ONe
H
K
Na
K Thick ascending
limb
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effects of either loop diuretics or distally acting diuretics given
alone.
We noted that the effects of hydrochlorothiazide and of
tizolemide upon distal tubular and urinary potassium transport
were modified significantly when these two diuretics were given
together with either furosemide or piretanide. Comparison of
the results summarized in Table 5 shows significant attentuation
of potassium secretion along the distal tubule following admin-
istration of loop diuretics with either hydrochlorothiazide or
tizolemide. Both of these diuretics when given together with
loop diuretics blocked distal tubular potassium secretion. This
effect is surprising since both hydrochiorothiazide and
tizolemide stimulate potassium secretion when given alone
(Table 5). The explanation of this unexpected interaction is not
evident.
Effects on urinary acidification
The administration of loop diuretics led to significant modi-
fications of urinary acidification. Following furosemide or
piretanide, urinary pH fell and the excretion of phosphate,
titratable acid, and ammonium increased. These effects were
attenuated strongly by amiloride and by triamterene. Our
analysis of distal tubular acidification parameters indicated that
both loop diuretics lowered tubular pH by the time fluid had
reached the earliest part of the distal tubule. This locates the
site of enhanced acidification after furosemide or piretanide in
the loop of Henle, most likely along the thick ascending limb. A
similar site of stimulation of acidification by loop diuretics had
been observed by Vincent and Hutcheon during stop-flow
experiments in dogs [43].
The following mechanism is most likely to account for the
stimulation of acidification by furosemide and piretanide. Fig-
ure 3 incorporates some features of relevant transport mecha-
nisms. The presence of both Na/H and HC03/C1 exchang-
ers has been observed recently in the apical membrane of
isolated cortical thick limbs from mouse kidney [44]. Such a
dual exchange mechanism per se would not lead to net acidifi-
cation, but it is likely that the Na/H exchanger predominates
in the rat kidney in view of recent results showing the ability of
this nephron segment to acidify luminal fluid and to reabsorb
bicarbonate [45]. Also, Figure 3 reveals the presence of a
Na-K-2Cl cotransport system that is sensitive to loop
diuretics. The operation of these co- and counter-transport
mechanisms may form the basis for the distal acidifying effect of
loop diuretics. In the amphibian early distal tubule, a diluting
segment sharing many functional properties with the thick
ascending limb of Henle's loop [46], the cellular sodium activity
drops sharply after perfusing the lumen with a furosemide-
containing solution. Apparently, a sharp fall in cell sodium
activity follows diminished sodium entry and continuing
peritubular sodium extrusion [47]. Accordingly, the sodium
concentration gradient across the luminal membrane steepens,
thus providing effective stimulation for the luminal Na*/H+
exchanger. Alternatively, since loop diuretics cause virtual
abolition of the lumen-positive potential difference of the thick
ascending limb [3], enhanced acidification of the tuminal fluid
may be the result of decreased diffusional exit of H and of NH4
out of the lumen, presumably via the intercellular pathway.
Increased generation of titratable acidity along the distal
tubule and augmentation of distal ammonium delivery logically
would be the consequence of enhanced distal acidification. An
additional element in the stimulation of titratable acid excretion
following ioop diuretics has to do with the marked phosphaturia
that was noted after furosemide and piretanide (Table 4). Such
an effect on piiosphate excretion has been noted in dog [48] and
man [49]. From our experiments we cannot determine the
precise site of action or the mechanism underlying this effect.
The proximal tubule, the loop of Henle, and the late distal
tubule all have been defined as significant sites of phosphate
reabsorption [50, 51]. It may be relevant that titratable acid,
once generated in the proximal tubule, is normally lost in
non-diuretic conditions during the passage of tubular fluid along
the loop of Henle; such disappearance of titratable acid is
diminished during saline diuresis [12]. Others have shown the
possibilty that loop diuretics interfere with proximal tubular
function, including phosphate reabsorption [48, 52]. Alterna-
tively, the impediment of phosphate reabsorption could occur
along the ioop of Henle. Clearly, additional experiments will be
necessary to elucidate the nephron site(s) and mechanisms that
underlie the observed phosphaturia following loop diuretic
administration.
It should be emphasized that increased urine flow does not
always enhance titratable acid loss. Following infusion of
increasing amounts of saline, urine pH rises and thereby limits
the excretion of titratable acid [12). Under these experimental
conditions, in contrast to the situation of enhanced urine flow
by diuretics as noted above, titratable acid excretion remains
constant, despite a dramatic increase in urine flow rate and in
phosphate excretion.
Concerning the observed stimulation of ammonium excretion
following loop diuretics, it is most reasonable to implicate the
fall in tubular pH and the increased flow rate as important
factors. Flow-dependence of distal tubular ammonium produc-
tion [12] (and the ability of segments of the thick ascending
limb, of the distal tubule, and of the cortical collecting tubule to
generate ammonium) has been demonstrated recently [12].
The overall renal effect of loop diuretics upon acid-base
balance is that of induced net acid loss. Although urinary
bicarbonate concentrations were not measured in our experi-
ments, the pH values in the range of 5.16 to 5.25 after
furosemide and piretanide, respectively, make it certain that its
excretion rate must have been quite low and much too small to
offset the large rise in titratable acid and ammonium excretion
rate after furosemide and piretanide (Table 4). It has been
suggested by Bosch et a! [56] that furosemide could contribute
directly to the generation of metabolic alkalosis. These inves-
tigators observed the development of metabolic alkalosis in
furosemide-treated dogs in which net acid excretion rose at a
time when urinary salt loss was controlled carefully. Our
studies provide evidence that the distal nephron is a key site for
this effect.
We have shown in the present experiments that both
amiloride and triamterene reverse the effects of loop diuretics
on pH, titratable acid, and ammonium excretion. Within the
framework of present theories of tubular acidification, it is most
likely that these effects are mediated by the previously de-
scribed effects of amiloride, and, possibly, of triamterene, on
the electrical potential difference across the distal tubule and
the cortical collecting duct. Hydrogen ion secretion across the
cortical and medullary collecting tubule has been shown to
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proceed by a sodium-independent, electrogenic mechanism [54,
55, 60], and it is likely that the intercalated cell population of the
cortical collecting tubule is the site of this acidification mecha-
nism [57]. In view of the electrogenic nature of collecting tubule
hydrogen-ion secretion, changes in the electrical polarization of
this tubular segment are expected to influence hydrogen ion
transport. Such an effect has been observed in the turtle urinary
bladder [58]. In this preparation, as well as in the cortical
collecting tubule, the inhibitory effect of amiloride on hydrogen
ion secretion is thought to be due to the adverse electrical
potential gradient against which hydrogen ion secretion pro-
ceeds, following hyperpolarization of the apical cell membrane
[32, 59]. Ultimately, the effect of amiloride upon tubular acidi-
fication is elicited by its ability to block sodium permeability,
and to affect the electrical polarization of those nephron sites
where hydrogen ion transport is sensitive to electrical potential
changes.
In conclusion, our experiments have dealt with the effects
and interactions of several diuretics, either given alone or in
combination. The loop diuretics, furosemide and piretanide, in
addition to having marked natriuretic and kaliuretic effects
along the thick ascending limb of Henle's loop and the distal
tubule, have significant effects on tubular acidification. They
lower pH and increase urinary phosphate, titratable acid, and
ammonium excretion. These effects on acidification occur along
the thick ascending limb and the distal tubule. Amiloride and
triamterene suppress both the kaliuresis and the changes in acid
and ammonium excretion induced by loop diuretics.
Hydrochiorothiazide and tizolemide inhibit sodium reabsorp-
tion and stimulate potassium secretion along the distal tubule,
but when given together with furosemide or piretanide, the
effects of the ioop diuretics on sodium delivery tend to domi-
nate the function of this nephron segment. In addition, we have
shown that administration of triamterene with loop diuretics
attenuates the effect of the latter along the thick ascending limb
of Henle's loop.
Acknowledgments
Portions of this work have been published in preliminary form
(Kidney mt 14:762, 1978, and in Diuretika, edited by KRUCK F and
SCHREY A, New York, Springer-Verlag, 1980, pp 42—52).
This work was supported by National Institutes of Health Grant
AM17433-05. Dr. Hropot received support from Hoechst A.G., Frank-
furt a.M., West Germany, and Hoechst-Roussel, Somerville, New
Jersey, USA.
The authors thank Dr. M. Field for comments, criticism, and assist-
ance in manuscript preparation.
This paper is dedicated to Dr. Roman Muschaweck on his 65th
birthday.
Reprint requests to Dr. G. Giebisch, Department of Physiology, Yale
University School of Medicine, P.O. Box 3333, New Haven, Connect-
iCut 06510 USA
References
1. DUARTE CG, CHOMETY F, GIEBISCH 0: Effect of amiloride,
ouabain and furosemide on distal tubular function in the rat. Am J
Physiol 221:632—639, 1971
2. GIEBISCH G: Effects of diuretics on renal transport of potassium, in
Methods in Pharmacology edited by MARTINEZ-MALDONADO M,
New York, Plenum, 1976, vol. 4A, pp 121—164
3. BURG M, STONER L, CARDINAL J, GREEN N: Furosemide effect on
isolated uerfused tubules. Am J Physiol 225:119—124, 1973
4. SCHLATTER E, GREGER R, WEIDTKE C: Effect of "high ceiling"
diuretics on active salt transport in the cortical thick ascending limb
of Henle's loop of rabbit kidney. Pflugers Arch 396:210—217, 1983
5. ODLIND B, BEERMANN B, SELEN G, PERSSON AEG: Rehal tubular
secretion of piretanide and its effects on electrolyte reabsorption
and tubulo-glomerular feedback mechanism. J Pharmaco! Exp Ther
225:742—746, 1983
6. KUNAU RT, WELLER DR 3R, Wase HL: Clarification of the site of
action of chlorothiazide in the rat nephron. J Gun Invest
56:401—407, 1975
7. LACY FB, DOBYAN DC, JAMISON RL: Effect of triamterene on the
mammalian distal tubule in vivo. Renal Physiol, Base! 2:36—43,
1979/80
8. LANG Hi, KNABE B, MUSCHAWECK R, LINDNER E, HROPOT M:
4-(3-sulfamoyl-phenyl) thiazolidin-4-ols, a novel class of sulfona-
mide compounds with salidiuretic activity. Diuretic Agents, ACS
Symposium Series 83, Washington, D.C., American Chemical
Society, 1978
9. WIEBELHAUS VD, BRENNAN FT. SOSKNOWSKI G, MAAS AR,
WEINSTOCK J, BENDER AD: The natriuretic and diuretic character-
istics of triamterene in the dog. Arch mt Pharmacodyn Ther
169:429—451, 1967
10. KARLMARK B, JAEGER P, FEIN H, GIEBI5cH G: Coulometric
acid-base titration in nanoliter samples with glass and antimony
electrodes. Am J Physiol 242:F95—F99, 1982
11. KARLMARK B, JAEGER P, GIEBIscH G: Luminal buffer transport in
rat cortical tubule: relationship to potassium metabolism, Am J
Physiol 245:F584—F592, 1983
12. WiLcox C, GRANGES F, KIRK G, GORDON D, GIEBISCH 0: Effects
of saline infusion on titratable acid generation and ammonia secre-
tion. Am J Physiol 247:F50&-F519, 1984
13. CHEN PS .JR, TORIGARA TY, WARNER H: Microdetermination of
phosphorus. Anal Chem 28:1756—1758, 1956
14. HURST RO: The determination of nucleotide phosphorus with a
stanous-chloride-hydrazine sulphate reagent. Can J Biochem
42:287—297, 1964
15. DAFONSECA-WOLLHEIM K: Bedeuntung von Wasserstof-
fionenkonzentration und ADP-Zusatz bei der Ammoniakbestim-
mung mit Glutamatdehydrogenase. Kim Chem Kiln Biochem
11:421—426, 1973
16. FLOItE5 IM, DE MELLO AIRES M, MALNIC G: Effect of furosemide
on urinary acidification during alterations of acid-base equilibrium
in the rat. JBras Nefrol 1:51—58, 1979
17. DEET3EN P: Mikropunktionsuntersuchungen zur Wirkung von Fu-
rosemide. P!fugers Arch 284:184—190, 1965
18. MENG K: Mikropunktionsuntersuchungen Ober die salidiuretische
Wirkung von Hydrochlorothiazid, Acetazolamid und Furosemid.
Naunyn Schmiedebergs Arch Pharmacol 257:355—371, 1967
19. JAEGER P, KARLMARK B, GIEBISCH G: Ammonium transport in rat
cortical tubule: relationship to potassium metabolism. Am J Physioi
245 (Renal Fluid Electrolyte Physiol 14):F593—F600, 1983
20. GREGER R, SCHLATrER E: Properties of the lumen membrane of the
cortical thick ascending limb of Henle's loop of rabbit kidney.
Pflugers Arch 396:315—324, 1983
21. MURER H, GREGER R: Membrane transport in the proximal tubule
and thick ascending limb of Henle's loop: mechanisms and their
alterations. Kiln Wochenschr 60:1103—1113, 1982
22. ELLISON DH, VELAZQUEZ HE, WRIGHT FS: Stimulation of distal
potassium secretion by low luinen chloride in the presence of
barium. Am J Physiol 248:F638—F649, 1985
23. MORGAN T, TADOKORO M, MARTIN D, BERLINER RW: Effect of
furosemide on Na and K transport studied by microperfusion of
the rat nephron. Am J Physiol 218:292—297, 1970
24. STONER LC, TRIMBLE ME: Effects of MK-196 and furosemide on
rat medullary thick ascending limbs of Henle in vitro, J Pharmaco!
Exp Ther22I:715—720, 1982
25. PENNEL JP, LACY FB, JAMISON RL: An in vivo study of the
concentrating process in the descending limb of Henle's loop.
Kidney hit 5:337—347, 1974
26. GOLDBERG M: Ethacrynic acid: site and mode of action. Ann NY
Acad Sd 139:443—452, 1966
27. KHURI RN, WIEDERHOLT M, STRIEDER N, GIEBISCH 0: Effects of
flow rate and potassium intake on distal tubular potassium transfer.
Diuretic action on distal tubule 489
Am J Physiol 228:1249—1261, 1975
28. VELAZQUEZ H, WRIGHT FS: Renal distal tubule pathways for
sodium, chloride and potassium transport assessed by diuretics
(absi). Kidney mt 23:269, 1983
29. GooD DW, WRIGHT FS: Luminal influences on potassium secre-
tion: sodium concentration and fluid flow rate. Am J Physiol 236
(Renal Fluid Electrolyte Physiol 5):Fl92—F205, 1979
30. BENOS DJ: Amiloride: a molecular probe of sodium transport in
tissues and cells. Am J Physiol 242 (Cell Physiol 1l):C131—C145,
1982
31. O'NEIL R, BOULPAEP F: Effect of amiloride on the apical cell
membrane cation channels of a sodium-absorbing, potassium-
secreting renal epithelium. J Mem Biol 50:365—387, 1979
32. KOEI'PEN BM, GIEBI5CH G, BIAGI BA: Electrophysiology of mam-
malian renal tubules: inferences from intracellular microelectrode
studies. Annu Rev Physiol 45:497—517, 1983
33. Goor DW, VELAZQUEZ H, WRIGHT FS: Luminal influences on
potassium secretion: low sodium concentration. Am J Physiol 246
(Renal Fluid Electrolyte Physiol 15):F609—F619, 1984
34. STONER LC, BURG MB, ORLOFF J: Ion transport in cortical
collecting tubule: effect of amiloride. Am J Physiol 227:453—459,
1974
35. STOTE RM, ALEXANDER F, FAMILIAR RG: Effect of triamterene on
furosemide induced kaliuresis in normal volunteers (abstract). J mt
MedRes2:379, 1974
36. BARRATT U: The effect of amiloride on the transepithelial potential
difference of the distal tubule of the rat kidney. Pflugers Arch
361:251—254, 1976
37. ODLIND B: Relation between renal tubular secretion and effects of
five loop diuretics. J Pharmacol Exp Ther 211:238—244, 1979
38. BRATER DC: Pharmacodynamic considerations in the use of diuret-
ics. Annu Rev Pharmacol Toxicol 23:45—62, 1983
39. HROPOT M, SORGEL F, SI5TOVARIS N, MEISTER M, GIEBIscH G:
Interaction between furosemide and distal" diuretics—clearance
and micropuncture study (abstract). Proc VIlith mt Congr
Nephrol, 1981 p 191
40. COSTANZO LS, WINDHAGER FE: Calcium and sodium transport by
the distal convoluted tubule of the rat. Am J Physiol
235(5):F492—F506, 1978
41. GOLDBERG M: The renal physiology of diuretics, in Handbook of
Physiology (Sec 8), Renal Physiology, edited by ORLOFF J and
BERLINER RW, Washington, D.C., American Physiological Soci-
ety, 1973, p 1003—1032
42. FERNANDEZ PC, PUSCHETT JB: Proximal tubular actions of
metolazone and chlorothiazide. Am J Physiol 225:954—961, 1973
43. VINCENT ME, HUTCHEON DE: Association between sites of renal
hydrogen ion secretion and blockage of chloride reabsorption after
loop diuretics (abstract). Gun Res 29:687A, 1981
44. FRIEDMAN PA, ANDREOLI TE: C02-stimulated NaCI absorption in
the mouse renal cortical thick ascending limb of Henle. Evidence
for synchronous Na/H and Cl/HCO3 exchange in apical plasma
membranes. J Gen Physiol 80:683—711, 1982
45. Goor DW, KNEPPER MA, BURG MB: Ammonia and bicarbonate
transport by thick ascending limb of rat kidney. Am J Physiol
247:F35—F44, 1984
46. OBERLEITHNER H, GIEBISCFI G, LANG F, WANG W: Cellular
mechanism of the furosemide sensitive transport system in the
kidney. Klin Wochenschr60:1173—1l79, 1982
47. OBERLEITHNER H, LANG F, WANG W, GIEBISCH G: Effects of
inhibition of chloride transport on intracellular sodium activity in
distal amphibian nephron. Pflugers Arch 394:55—60, 1982
48. HAAS JA, LARSON MV, MARCHAND GR, LANG FC, GREGER RF,
KNOX FG: Phosphaturic effect of furosemide: role of PTH and
carbonic anhydrase. Am J Physiol 232:Fl05—F1 10, 1977
49. MARTINEZ-MALDONADO M, EKNOYAN G: Role of extracellular
fluid volume expansion and diuretics in renal handling of phos-
phate, in Renal Handling of Phosphate, edited by MASSRY SG and
FLEISCH H, New York and London, Plenum, 1980, pp 265—285
50. KNOX FG, OSSWALD H, MARCHAND GR, SPIELMAN WS, HAAS
JA, BERNOT T, YOUNGBERG SP: Phosphate transport along the
nephron. Am J Physiol 233:F261—F268, 1977
51. AMIEL C: Sites of renal tubular reabsorption of phosphate, in Renal
Handling of Phosphate, edited by MASSRY SG and FLEISCH H,
Plenum, New York and London, 1980, pp 39—57
52. BRENNER BM, KEIM0wITz RI, WRIGHT FS, BERLINER RW: An
inhibitory effect of furosemide on sodium reabsorption by the
proximal tubule of the rat nephron. J Clin Invest 48:290—300, 1969
53. GOOD DW, BURG MB: Ammonia production by individual seg-
ments of the rat nephron. J Cliii Invest 73:602—610, 1984
54. KOEPPEN BM, HELMAN SI: Acidification of luminal fluid by the
rabbit cortical collecting tubule perfused in vitro. Am J Physiol
242:F521—F531, 1982
55. LOMBARD WE, KOKKO JP, JACOBSON HR: Bicarbonate transport in
cortical and outer medullary collecting tubules. Am J Physiol
244:F289—F296, 1983
56. BOSCH JP, GOLDSTEIN MH, LEVITT MF, KAHN TH: Effect of
chronic furosemide administration on hydrogen and sodium excre-
tion in the dog. Am J Physiol 232:F397—F404, 1977
57. MADSEN KM, FISCHLSCHWEIGER W, TISCHER CC: Structural
characteristics of intercalated cells (IC) of rat collecting duct during
augmented hydrogen (H) secretion (abstr). Clin Res 29:850A, 1981
58. STEINMETZ PR: Cellular mechanism of urinary acidification. Phys-
iol Rev 54:890—956, 1974
59. HUSTED RF, STEINMETZ PR: The effects of amiloride and ouabain
on urinary acidification by turtle bladder. J Pharmacol Exp Ther
210:264—268, 1979
60. LASKIME, KURTZMAN NA: Characterization of acidification in the
cortical and medullary collecting tubule of the rabbit. J Clin Invest
72:2050—2059. 1983
